Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Clene Inc. Director's Dealing 2021

May 25, 2021

34487_dirs_2021-05-25_6cd49bb6-3d93-44f2-bdf0-20cd9cdb85cd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2021-05-18

Reporting Person: Mosca Alison (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-18 Stock Options (Right to buy) $9.10 A 2479.00 Acquired 2031-05-18 Common Stock (2479.00) Direct
2021-05-18 Stock Options (Right to buy) $9.10 A 30000.00 Acquired 2031-05-18 Common Stock (30000.00) Direct

Footnotes

F1: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 2,479.

F2: This option was granted on May18, 2021 as an option for 2,479 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant.

F3: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc.

F4: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested.